Apellis Pharmaceuticals (NASDAQ:APLS) Shares Down 3% After Analyst Downgrade
MarketBeatApellis Pharmaceuticals (NASDAQ:APLS) Stock Price Down 3% After Analyst Downgrade
Apellis Pharmaceuticals (NASDAQ:APLS) Stock Price Down 3% After Analyst Downgrade